
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $330.1M | $452.2M | $631.2M | $797.8M | $936.4M | |
Revenue Growth (YoY) | 23.55% | 36.99% | 39.57% | 26.4% | 17.37% | |
Cost of Revenues | $79.7M | $107.7M | $150.5M | $184.5M | $210.3M | |
Gross Profit | $250.4M | $344.5M | $480.7M | $613.3M | $726.1M | |
Gross Profit Margin | 75.85% | 76.18% | 76.16% | 76.88% | 77.55% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $36.8M | $49M | $64.3M | $75M | $82.2M | |
Other Inc / (Exp) | $13.4M | $32.1M | $6M | $17.2M | $15.8M | |
Operating Expenses | $152.1M | $200.3M | $261.1M | $319.5M | $357.4M | |
Operating Income | $98.4M | $144.3M | $219.6M | $293.8M | $368.7M | |
Net Interest Expenses | $30.8M | $40.1M | $48.5M | $61.4M | $98.6M | |
EBT. Incl. Unusual Items | $80.9M | $136.2M | $177.2M | $249.6M | $285.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | $80.9M | $136.2M | $177.2M | $249.6M | $285.9M | |
Minority Interest in Earnings | -$4.5M | -$8M | -$9.6M | -$11.6M | -$12.1M | |
Net Income to Common Excl Extra Items | $76.4M | $128.2M | $167.6M | $238M | $273.8M | |
Basic EPS (Cont. Ops) | $0.51 | $0.80 | $0.92 | $1.12 | $1.20 | |
Diluted EPS (Cont. Ops) | $0.51 | $0.80 | $0.92 | $1.12 | $1.20 | |
Weighted Average Basic Share | $120.9M | $139.3M | $170.5M | $202.9M | $218.3M | |
Weighted Average Diluted Share | $121.2M | $140.1M | $171M | $203.1M | $218.5M | |
EBITDA | $227M | $327.7M | $422.4M | $555.5M | $659.8M | |
EBIT | $111.7M | $176.4M | $225.7M | $311M | $384.5M | |
Revenue (Reported) | $330.1M | $452.2M | $631.2M | $797.8M | $936.4M | |
Operating Income (Reported) | $98.4M | $144.3M | $219.6M | $293.8M | $368.7M | |
Operating Income (Adjusted) | $111.7M | $176.4M | $225.7M | $311M | $384.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $99.8M | $140.8M | $186.2M | $214.1M | $252.3M | |
Revenue Growth (YoY) | 28.43% | 41.09% | 32.32% | 14.96% | 17.84% | |
Cost of Revenues | $23.6M | $33.4M | $42.8M | $47.5M | $55.3M | |
Gross Profit | $76.2M | $107.3M | $143.4M | $166.6M | $197M | |
Gross Profit Margin | 76.37% | 76.25% | 77.01% | 77.82% | 78.1% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $11.5M | $14.7M | $18.2M | $20M | $19.9M | |
Other Inc / (Exp) | $10.8M | $8.4M | $11.5M | -$1.4M | $10.9M | |
Operating Expenses | $46.6M | $57.2M | $77.6M | $86.3M | $106.6M | |
Operating Income | $29.6M | $50.1M | $65.8M | $80.4M | $90.4M | |
Net Interest Expenses | $9.8M | $9.7M | $13.7M | $14.7M | $27.3M | |
EBT. Incl. Unusual Items | $30.6M | $48.9M | $63.6M | $64.3M | $74M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | $30.6M | $48.9M | $63.6M | $64.3M | $74M | |
Minority Interest in Earnings | -$2M | -$2.5M | -$3.1M | -$2.9M | -$2.8M | |
Net Income to Common Excl Extra Items | $28.7M | $46.4M | $60.5M | $61.4M | $71.2M | |
Basic EPS (Cont. Ops) | $0.19 | $0.27 | $0.30 | $0.27 | $0.30 | |
Diluted EPS (Cont. Ops) | $0.19 | $0.27 | $0.30 | $0.27 | $0.30 | |
Weighted Average Basic Share | $131.6M | $160.6M | $195.4M | $214.4M | $227.4M | |
Weighted Average Diluted Share | $131.8M | $161M | $195.8M | $214.4M | $227.4M | |
EBITDA | $75.5M | $101.1M | $136.7M | $145.2M | $188.1M | |
EBIT | $40.4M | $58.6M | $77.3M | $78.9M | $101.3M | |
Revenue (Reported) | $99.8M | $140.8M | $186.2M | $214.1M | $252.3M | |
Operating Income (Reported) | $29.6M | $50.1M | $65.8M | $80.4M | $90.4M | |
Operating Income (Adjusted) | $40.4M | $58.6M | $77.3M | $78.9M | $101.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $352.2M | $493.2M | $676.7M | $825.7M | $974.6M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $85.2M | $117.6M | $159.9M | $189.1M | $218M | |
Gross Profit | $267M | $375.7M | $516.8M | $636.6M | $756.6M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $39M | $52.2M | $67.7M | $76.8M | $82M | |
Other Inc / (Exp) | $24.2M | $29.7M | $9M | $4.3M | $28.1M | |
Operating Expenses | $161.8M | $210.8M | $281.5M | $328.2M | $377.8M | |
Operating Income | $105.2M | $164.8M | $235.3M | $308.4M | $378.8M | |
Net Interest Expenses | $33.2M | $40.1M | $52.5M | $62.4M | $111.2M | |
EBT. Incl. Unusual Items | $96.3M | $154.5M | $191.8M | $250.3M | $295.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | $96.3M | $154.5M | $191.8M | $250.3M | $295.7M | |
Minority Interest in Earnings | -$5.7M | -$8.5M | -$10.2M | -$11.4M | -$12.1M | |
Net Income to Common Excl Extra Items | $90.5M | $146M | $181.7M | $238.9M | $283.6M | |
Basic EPS (Cont. Ops) | $0.61 | $0.88 | $0.95 | $1.09 | $1.24 | |
Diluted EPS (Cont. Ops) | $0.60 | $0.88 | $0.95 | $1.09 | $1.24 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $252.3M | $353.2M | $458.1M | $564M | $702.6M | |
EBIT | $129.4M | $194.6M | $244.3M | $312.7M | $406.9M | |
Revenue (Reported) | $352.2M | $493.2M | $676.7M | $825.7M | $974.6M | |
Operating Income (Reported) | $105.2M | $164.8M | $235.3M | $308.4M | $378.8M | |
Operating Income (Adjusted) | $129.4M | $194.6M | $244.3M | $312.7M | $406.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $99.8M | $140.8M | $186.2M | $214.1M | $252.3M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $23.6M | $33.4M | $42.8M | $47.5M | $55.3M | |
Gross Profit | $76.2M | $107.3M | $143.4M | $166.6M | $197M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $11.5M | $14.7M | $18.2M | $20M | $19.9M | |
Other Inc / (Exp) | $10.8M | $8.4M | $11.5M | -$1.4M | $10.9M | |
Operating Expenses | $46.6M | $57.2M | $77.6M | $86.3M | $106.6M | |
Operating Income | $29.6M | $50.1M | $65.8M | $80.4M | $90.4M | |
Net Interest Expenses | $9.8M | $9.7M | $13.7M | $14.7M | $27.3M | |
EBT. Incl. Unusual Items | $30.6M | $48.9M | $63.6M | $64.3M | $74M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | $30.6M | $48.9M | $63.6M | $64.3M | $74M | |
Minority Interest in Earnings | -$2M | -$2.5M | -$3.1M | -$2.9M | -$2.8M | |
Net Income to Common Excl Extra Items | $28.7M | $46.4M | $60.5M | $61.4M | $71.2M | |
Basic EPS (Cont. Ops) | $0.19 | $0.27 | $0.30 | $0.27 | $0.30 | |
Diluted EPS (Cont. Ops) | $0.19 | $0.27 | $0.30 | $0.27 | $0.30 | |
Weighted Average Basic Share | $131.6M | $160.6M | $195.4M | $214.4M | $227.4M | |
Weighted Average Diluted Share | $131.8M | $161M | $195.8M | $214.4M | $227.4M | |
EBITDA | $75.5M | $101.1M | $136.7M | $145.2M | $188.1M | |
EBIT | $40.4M | $58.6M | $77.3M | $78.9M | $101.3M | |
Revenue (Reported) | $99.8M | $140.8M | $186.2M | $214.1M | $252.3M | |
Operating Income (Reported) | $29.6M | $50.1M | $65.8M | $80.4M | $90.4M | |
Operating Income (Adjusted) | $40.4M | $58.6M | $77.3M | $78.9M | $101.3M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $176.3M | $44M | $36.8M | $33.4M | $56M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $51.1M | $72.5M | $103.4M | $140.8M | $177.5M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $4.1M | $8.4M | $1.6M | $2.1M | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $241.5M | $132.2M | $141.8M | $299.2M | $356.7M | |
Property Plant And Equipment | -- | -- | -- | -- | -- | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | $97.3M | $137.3M | $175.1M | $158.8M | $206.6M | |
Other Long-Term Assets | $14.4M | $19.1M | $25M | $25.2M | $27M | |
Total Assets | $5B | $6.8B | $9.3B | $10.9B | $12.6B | |
Accounts Payable | $45.4M | $65.8M | $97.5M | $128.8M | $149.7M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $193K | $231K | -- | -- | -- | |
Total Current Liabilities | $119.6M | $179.4M | $252.2M | $412.4M | $428.8M | |
Long-Term Debt | $1.2B | $1.4B | $1.9B | $2.2B | $3.3B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.4B | $1.7B | $2.3B | $2.8B | $3.9B | |
Common Stock | $243.6M | $157.3M | $157.6M | $157.8M | $157.9M | |
Other Common Equity Adj | -$17.7M | -$9.9M | $8.2M | $7.2M | $6.7M | |
Common Equity | $3B | $4.6B | $6.4B | $7.6B | $8.2B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $285.5M | $283.1M | $366.4M | $377M | $401.9M | |
Total Equity | $3.5B | $5.1B | $6.9B | $8.1B | $8.7B | |
Total Liabilities and Equity | $5B | $6.8B | $9.3B | $10.9B | $12.6B | |
Cash and Short Terms | $176.3M | $44M | $36.8M | $33.4M | $56M | |
Total Debt | $1.2B | $1.4B | $1.9B | $2.2B | $3.3B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $123.9M | $48.8M | $253.6M | $337M | $504.6M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $52.8M | $79M | $108.8M | $148.6M | $184.5M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $10.1M | $18.3M | $3.6M | $8M | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | $186.9M | $146.1M | $382.3M | $616.4M | $880.9M | |
Property Plant And Equipment | -- | -- | -- | -- | -- | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | $92.7M | $158.8M | $166.5M | $228.9M | $187.6M | |
Other Long-Term Assets | $27.3M | $22.7M | $21.8M | $22.1M | $20.7M | |
Total Assets | $5.1B | $7.3B | $10.2B | $12.4B | $13.1B | |
Accounts Payable | $41.9M | $85.5M | $110.3M | $148.9M | $142M | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | $234K | |
Total Current Liabilities | $121.3M | $215.5M | $311M | $445M | $426.4M | |
Long-Term Debt | $1.2B | $1.5B | $2.2B | $3.3B | $3.3B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.4B | $1.9B | $2.7B | $4B | $3.9B | |
Common Stock | $243.7M | $157.3M | $157.7M | $157.9M | $158M | |
Other Common Equity Adj | -$14M | -$3.7M | $3.1M | $13.9M | $3.6M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $288.7M | $299.2M | $371.5M | $381.1M | $371.6M | |
Total Equity | $3.6B | $5.4B | $7.6B | $8.4B | $9.2B | |
Total Liabilities and Equity | $5.1B | $7.3B | $10.2B | $12.4B | $13.1B | |
Cash and Short Terms | $123.9M | $48.8M | $253.6M | $337M | $504.6M | |
Total Debt | $1.2B | $1.5B | $2.2B | $3.3B | $3.3B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $80.9M | $136.2M | $177.2M | $249.6M | $285.9M | |
Depreciation & Amoritzation | $104.7M | $135.8M | $165.6M | $214.6M | $247.6M | |
Stock-Based Compensation | $12.9M | $19.5M | $28.4M | $33.6M | $41.6M | |
Change in Accounts Receivable | $16.3M | -$745K | -$2.9M | -$2.2M | $2.3M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $183M | $231.5M | $327.7M | $427.5M | $478.9M | |
Capital Expenditures | $78.8M | $102.5M | $135.1M | $266.6M | $373.4M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$987.5M | -$1.9B | -$2.4B | -$1.7B | -$1.8B | |
Dividends Paid (Ex Special Dividend) | -$119.7M | -$151.6M | -$222.9M | -$314.7M | -$379.6M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $471.8M | $1.3B | $2.7B | $646.9M | $1.1B | |
Long-Term Debt Repaid | -$175.7M | -$1.1B | -$2.2B | -$357.5M | -$13.4M | |
Repurchase of Common Stock | -$1.3M | -$91.4M | -$2.2M | -$1.9M | -$2.3M | |
Other Financing Activities | -$6.1M | -$4.6M | -$7.3M | -$3M | -$4.6M | |
Cash From Financing | $903.2M | $1.5B | $2.1B | $1.2B | $1.4B | |
Beginning Cash (CF) | $78.9M | $177.5M | $44M | $36.8M | $33.4M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $98.7M | -$133.5M | -$7.2M | -$3.3M | $22.5M | |
Ending Cash (CF) | $177.5M | $44M | $36.8M | $33.4M | $56M | |
Levered Free Cash Flow | $104.2M | $129M | $192.6M | $161M | $105.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $30.6M | $48.9M | $63.6M | $64.3M | $74M | |
Depreciation & Amoritzation | $32.4M | $37.4M | $51.1M | $58.7M | $77.6M | |
Stock-Based Compensation | $4.3M | $6.1M | $8.2M | $9.1M | $9.7M | |
Change in Accounts Receivable | $2.5M | $1.2M | $1.4M | -$402K | -$1.9M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $36.4M | $91.6M | $119.5M | $133.8M | $152.6M | |
Capital Expenditures | $23.1M | $27.3M | $44.2M | $79.9M | $79.1M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$172.4M | -$471.6M | -$765.9M | -$1.2B | -$29M | |
Dividends Paid (Ex Special Dividend) | -$34.1M | -$43.2M | -$65.1M | -$86.8M | -$100.5M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $392M | $646.9M | $1.1B | -- | |
Long-Term Debt Repaid | -$319K | -$267.6M | -$350.4M | -$3.9M | -$239K | |
Repurchase of Common Stock | -$1.4M | -$2M | -$1.7M | -$2M | -$1.6M | |
Other Financing Activities | -- | -- | -$2.8M | -$3.7M | -- | |
Cash From Financing | $82.5M | $384.9M | $879.4M | $1.3B | $375.2M | |
Beginning Cash (CF) | $177.5M | $44M | $36.8M | $33.4M | $56M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$53.5M | $4.8M | $233.1M | $303.5M | $498.7M | |
Ending Cash (CF) | $124M | $48.8M | $269.9M | $337M | $554.7M | |
Levered Free Cash Flow | $13.2M | $64.3M | $75.3M | $53.9M | $73.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $96.3M | $154.5M | $191.8M | $250.3M | $295.7M | |
Depreciation & Amoritzation | $112M | $140.8M | $179.3M | $222.2M | $266.5M | |
Stock-Based Compensation | $13.6M | $21.3M | $30.6M | $34.5M | $42.2M | |
Change in Accounts Receivable | $18.5M | -$2.1M | -$2.7M | -$4M | $806K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $172.9M | $286.7M | $355.6M | $441.8M | $497.7M | |
Capital Expenditures | $86.3M | $106.6M | $152.1M | $302.2M | $372.6M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$1.1B | -$2.2B | -$2.7B | -$2.1B | -$711.2M | |
Dividends Paid (Ex Special Dividend) | -$128.1M | -$160.7M | -$244.8M | -$336.4M | -$393.2M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $471.8M | $1.7B | $3B | $1.1B | -- | |
Long-Term Debt Repaid | -$175.9M | -$1.4B | -$2.3B | -$11M | -$9.7M | |
Repurchase of Common Stock | -$1.4M | -$92.1M | -$1.9M | -$2.2M | -$1.9M | |
Other Financing Activities | -- | -- | -$10.1M | -$3.9M | -- | |
Cash From Financing | $935.4M | $1.9B | $2.6B | $1.7B | $431.2M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $11.5M | -$75.1M | $221M | $67.1M | $217.7M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $86.6M | $180.1M | $203.6M | $139.6M | $125.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $30.6M | $48.9M | $63.6M | $64.3M | $74M | |
Depreciation & Amoritzation | $32.4M | $37.4M | $51.1M | $58.7M | $77.6M | |
Stock-Based Compensation | $4.3M | $6.1M | $8.2M | $9.1M | $9.7M | |
Change in Accounts Receivable | $2.5M | $1.2M | $1.4M | -$402K | -$1.9M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $36.4M | $91.6M | $119.5M | $133.8M | $152.6M | |
Capital Expenditures | $23.1M | $27.3M | $44.2M | $79.9M | $79.1M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -$172.4M | -$471.6M | -$765.9M | -$1.2B | -$29M | |
Dividends Paid (Ex Special Dividend) | -$34.1M | -$43.2M | -$65.1M | -$86.8M | -$100.5M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $392M | $646.9M | $1.1B | -- | |
Long-Term Debt Repaid | -$319K | -$267.6M | -$350.4M | -$3.9M | -$239K | |
Repurchase of Common Stock | -$1.4M | -$2M | -$1.7M | -$2M | -$1.6M | |
Other Financing Activities | -- | -- | -$2.8M | -$3.7M | -- | |
Cash From Financing | $82.5M | $384.9M | $879.4M | $1.3B | $375.2M | |
Beginning Cash (CF) | $177.5M | $44M | $36.8M | $33.4M | $56M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$53.5M | $4.8M | $233.1M | $303.5M | $498.7M | |
Ending Cash (CF) | $124M | $48.8M | $269.9M | $337M | $554.7M | |
Levered Free Cash Flow | $13.2M | $64.3M | $75.3M | $53.9M | $73.4M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.